Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current knowledge of heritable tumors.

W K Cavenee1

  • 1Montreal Branch, Ludwig Institute for Cancer Research, Quebec, Canada.

Birth Defects Original Article Series
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.

Oncogene·2025
Same author

IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Oncogene·2015
Same author

Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.

Oncogene·2014
Same author

EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.

Oncogene·2013
Same author

Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Current cancer drug targets·2012
Same author

EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.

Oncogene·2011
Same journal

A case of short-rib syndrome without polydactyly in a stillborn: a new type?

Birth defects original article series·1996
Same journal

Hand malformations in the aborted embryo: an important source of genetic information.

Birth defects original article series·1996
Same journal

Colophon: on doing morphology.

Birth defects original article series·1996
Same journal

Congenital eye malformations: a descriptive epidemiologic study in about one million newborns in Italy.

Birth defects original article series·1996
Same journal

CHARGE association in a neonate exposed in utero to carbon monoxide.

Birth defects original article series·1996
Same journal

Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.

Birth defects original article series·1996
See all related articles

A new model explains cancer development by uncovering recessive mutations through mitotic errors, leading to homozygous defects. This has significant implications for cancer risk assessment and diagnosis.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Cancer development involves genetic and molecular factors.
  • A model integrating genetic, epidemiologic, and cytogenetic data has emerged.
  • This model focuses on unmasking recessive mutations via mitotic events.

Purpose of the Study:

  • To present a model for cancer development involving homozygous defects.
  • To discuss the clinical and public health relevance of this model.
  • To explore the potential applications in cancer diagnosis and risk stratification.

Main Methods:

  • Consolidation of genetic, epidemiologic, and cytogenetic data.
  • Analysis of mitotic malsegregation and recombination events.
  • Application of molecular genetic techniques.

Related Experiment Videos

Main Results:

  • The model explains tumor progenitor formation through homozygous defects at specific loci.
  • Successful application in retinoblastoma and Wilms tumor.
  • Potential applicability to other solid tumors and equivocal diagnoses like soft tissue sarcomas.

Conclusions:

  • The model offers substantial relevance to clinical medicine and public health.
  • Further research is needed to define the role of environmental agents.
  • Genotypic analysis can aid in premorbid diagnosis and cancer risk assessment.